FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387671339> ?p ?o ?g. }

• W4387671339 abstract "Abstract Background The wide use of antibody‐drug conjugates (ADCs) is transforming the cancer‐treatment landscape. Understanding the treatment‐related adverse events (AEs) of ADCs is crucial for their clinical application. We conducted a meta‐analysis to analyze the profile and incidence of AEs related to ADC use in the treatment of solid tumors and hematological malignancies. Methods We searched the PubMed, Embase, and Cochrane Library databases for articles published from January 2001 to October 2022. The overall profile and incidence of all‐grade and grade ≥ 3 treatment‐related AEs were the primary outcomes of the analysis. Results A total of 138 trials involving 15,473 patients were included in this study. The overall incidence of any‐grade treatment‐related AEs was 100.0% (95% confidence interval [CI]: 99.9%–100.0%; I 2 = 89%) and the incidence of grade ≥ 3 treatment‐related AEs was 6.2% (95% CI: 3.0%–12.4%; I ² = 99%). Conclusions This study provides a comprehensive overview of AEs related to ADCs used for cancer treatment. ADC use resulted in a high incidence of any‐grade AEs but a low incidence of grade ≥ 3 AEs. The AE profiles and incidence differed according to cancer type, ADC type, and ADC components." @default.
• W4387671339 created "2023-10-17" @default.
• W4387671339 creator A5004740449 @default.
• W4387671339 creator A5011424703 @default.
• W4387671339 creator A5014942475 @default.
• W4387671339 creator A5023235979 @default.
• W4387671339 creator A5031944443 @default.
• W4387671339 creator A5038934949 @default.
• W4387671339 creator A5039851941 @default.
• W4387671339 creator A5049059298 @default.
• W4387671339 creator A5055003664 @default.
• W4387671339 creator A5058479146 @default.
• W4387671339 creator A5058480073 @default.
• W4387671339 creator A5060638114 @default.
• W4387671339 creator A5068596690 @default.
• W4387671339 creator A5076476567 @default.
• W4387671339 creator A5084815360 @default.
• W4387671339 date "2023-10-15" @default.
• W4387671339 modified "2023-10-17" @default.
• W4387671339 title "Treatment‐related adverse events of antibody‐drug conjugates in clinical trials: A systematic review and meta‐analysis" @default.
• W4387671339 cites W1488000644 @default.
• W4387671339 cites W1964449492 @default.
• W4387671339 cites W1971239728 @default.
• W4387671339 cites W1981354237 @default.
• W4387671339 cites W2006856311 @default.
• W4387671339 cites W2011118089 @default.
• W4387671339 cites W2033857851 @default.
• W4387671339 cites W2037994583 @default.
• W4387671339 cites W2046282385 @default.
• W4387671339 cites W2055342008 @default.
• W4387671339 cites W2056017799 @default.
• W4387671339 cites W2060466778 @default.
• W4387671339 cites W2062239549 @default.
• W4387671339 cites W2062486240 @default.
• W4387671339 cites W2065406906 @default.
• W4387671339 cites W2102429358 @default.
• W4387671339 cites W2107943299 @default.
• W4387671339 cites W2114282952 @default.
• W4387671339 cites W2115100262 @default.
• W4387671339 cites W2119799189 @default.
• W4387671339 cites W2120627364 @default.
• W4387671339 cites W2125435699 @default.
• W4387671339 cites W2127018518 @default.
• W4387671339 cites W2127742735 @default.
• W4387671339 cites W2128764431 @default.
• W4387671339 cites W2136145129 @default.
• W4387671339 cites W2136527721 @default.
• W4387671339 cites W2139891818 @default.
• W4387671339 cites W2145174107 @default.
• W4387671339 cites W2148594538 @default.
• W4387671339 cites W2151131052 @default.
• W4387671339 cites W2155256323 @default.
• W4387671339 cites W2156671071 @default.
• W4387671339 cites W2157501935 @default.
• W4387671339 cites W2157823046 @default.
• W4387671339 cites W2159967578 @default.
• W4387671339 cites W2160768181 @default.
• W4387671339 cites W2161569196 @default.
• W4387671339 cites W2204723260 @default.
• W4387671339 cites W2207853596 @default.
• W4387671339 cites W2246182250 @default.
• W4387671339 cites W2259204994 @default.
• W4387671339 cites W2315322079 @default.
• W4387671339 cites W2337841974 @default.
• W4387671339 cites W2419517407 @default.
• W4387671339 cites W2419639370 @default.
• W4387671339 cites W2500482667 @default.
• W4387671339 cites W2551315898 @default.
• W4387671339 cites W2567362164 @default.
• W4387671339 cites W2595349270 @default.
• W4387671339 cites W2598685895 @default.
• W4387671339 cites W2623658063 @default.
• W4387671339 cites W2625001871 @default.
• W4387671339 cites W2725721905 @default.
• W4387671339 cites W2730231599 @default.
• W4387671339 cites W2742474398 @default.
• W4387671339 cites W2761653596 @default.
• W4387671339 cites W2767597066 @default.
• W4387671339 cites W2794282975 @default.
• W4387671339 cites W2794872274 @default.
• W4387671339 cites W2800904527 @default.
• W4387671339 cites W2805275737 @default.
• W4387671339 cites W2889446347 @default.
• W4387671339 cites W2889957730 @default.
• W4387671339 cites W2892881565 @default.
• W4387671339 cites W2895691142 @default.
• W4387671339 cites W2898183660 @default.
• W4387671339 cites W2901760736 @default.
• W4387671339 cites W2902218997 @default.
• W4387671339 cites W2903892849 @default.
• W4387671339 cites W2909673413 @default.
• W4387671339 cites W2914068327 @default.
• W4387671339 cites W2914756882 @default.
• W4387671339 cites W2917403028 @default.
• W4387671339 cites W2923666301 @default.
• W4387671339 cites W2931981435 @default.
• W4387671339 cites W2936108326 @default.
• W4387671339 cites W2942867242 @default.
• W4387671339 cites W2943729639 @default.
• W4387671339 cites W2947718191 @default.

• next